Intravenous bisphosphonate for hypercalcemia accompanying subcutaneous fat necrosis: A novel treatment approach

Clinical Pediatrics

Volumn 40, Issue 4, 2001, Pages 217-219

  Khan, N ^a   Licata, A ^a   Rogers, D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCILO; CALCIUM; ETIDRONIC ACID; FUROSEMIDE; METHYLPREDNISOLONE;

ANTIBIOTIC THERAPY; ARTICLE; BIOPSY TECHNIQUE; CASE REPORT; DISEASE COURSE; DRUG EFFICACY; FAT NECROSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERCALCEMIA; INFANT; MALE; SUBCUTANEOUS FAT DISORDER; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0035063588     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992280104000407     Document Type: Article

References (10)

1. Etidronate therapy for hypercalcemia in subcutaneous fat necrosis of the newborn
2. Subcutaneous fat necrosis of the newborn and hypercalcemia: Case report and review of literature
3. Hypercalcemia with increased and unregulated 1,25 dihydroxy vitamin D production in a neonate with fat necrosis
4. Hypercalcemia in association with subcutaneous fat necrosis of the newborn: Studies of calcium regulating hormones
5. Prostaglandins, thromboxanes, and leukotrienes
6. Infantile hypercalcemia with subcutaneous fat necrosis: Endocrine studies
7. Infantile hypercalcemia with subcutaneous fat necrosis: Report of a case with studies on pathogenesis of hypercalcemia
8. Bisphosphonates: From grandparents to grandchildren
9. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta
10. Expanding role of bisphosphonate therapy in children